Skip to main content

APO IMA 400 Pill: orange , capsule/oblong, 17mm

The pill with imprint APO IMA 400 (Orange, Capsule/Oblong1) has been identified as Imatinib Mesylate 400 mg and is used for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, and Gastrointestinal Stromal Tumor. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.

Images for APO IMA 400

Imatinib mesylate 400 mg APO IMA 400
Imatinib mesylate 400 mg APO IMA 400
Imatinib mesylate 400 mg APO IMA 400

Imatinib Mesylate

Imprint
APO IMA 400
Strength
400 mg
Color
Orange
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
silicon dioxide, crospovidone, magnesium stearate, hypromellose 2910 (5 mPa.s), hydroxypropyl cellulose (type l), ferric oxide red, ferric oxide yellow, polyethylene glycol 8000

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
42291-0352 (Discontinued) AvKare, Inc.
60505-2901 Apotex Corp.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.